ClinicalTrials.gg
Not yet recruitingNCT07857395MEGRIUpdated Oct 5, 2026

Modified El-Ganzouri Risk Index for Predicting Difficult Intubation in Obese Patients

An observational study in Difficult Intubation and Obesity, sponsored by Zagazig University. Not yet recruiting at 1 site in Egypt. Open to participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Zagazig University · Observational

How we know

Updated Oct 5, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
114
Ages
21 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 138 studies in Obesity with a site in Egypt — 32 open to participants now, 39 under way, none of them phase 3. Obesity · Egypt.

Planned enrollment
15th of 36
114 · median 100
Started
2026
with 12 others
Observational
36 of 138
8 open now
Primary completion
2027-03
later than 34 of 38 live
Registered
136th of 138
by date
Lead sponsor
4 of 138
Zagazig University

Among the 138 studies in Obesity with a site in Egypt, this one is the 15th largest by planned enrollment of the 36 observational ones that give a count, is one of 13 that started in 2026, is one of 36 observational ones, reaches primary completion later than 34 of the 38 other live ones, and was the 136th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

32 of the 138 studies in Obesity with a site in Egypt are open now. Recruiting first, the newest first:

27 more — sign in →

All 32 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 21 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 138 studies in Obesity with a site in Egypt, or all of them as a file.
02

Study summary

This observational study aims to compare the predictive performance of the Modified El-Ganzouri Risk Index (MEGRI) incorporating anthropometric ratios with the original El-Ganzouri Risk Index (EGRI) for predicting difficult intubation in obese adult patients undergoing elective general anesthesia.

03

Conditions studied

  • Difficult Intubation
  • Obesity

Browse trials for

Keywords

  • El-Ganzouri Risk Index Modified El-Ganzouri Risk Index MEGRI Difficult Laryngoscopy Difficult Tracheal Intubation Anthropometric Ratios
04

Who can participate

Ages eligible
21 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Age: 21-65 years old.ASA: II,III.Obese patients (Body Mass Index (BMI) 30-40 kg/m² ) scheduled for elective surgical procedures under general anesthesia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient acceptance.
  • Age: 21-65 years old.
  • ASA: II,III.
  • Obese patients ( (BMI) 30-40 kg/m² ) scheduled for elective surgical procedures under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • Patients undergoing maxillofacial trauma surgery.
  • Patients with a history of neck surgery or cervical spine instability.
  • Pregnant patients, and those requiring rapid sequence intubation.
  • Upper airway pathology or surgery.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
114 participants (estimated)
Patient registry
No

Groups and cohorts

  • Obese Adult Patients

    Adult obese patients undergoing elective general anesthesia who will be assessed preoperatively using both the original El-Ganzouri Risk Index and the Modified El-Ganzouri Risk Index, followed by assessment of laryngoscopy and intubation outcomes.

    Other: No intervention

Interventions

  • OtherNo intervention

    This is an observational study. No study intervention is assigned. Patients receive standard anesthetic care, and preoperative airway assessment and intraoperative intubation outcomes are recorded for comparison of the original and Modified El-Ganzouri Risk Index.

06

What researchers measure

Primary outcomes

  1. Area Under the Receiver Operating Characteristic Curve (AUC) of the Modified El-Ganzouri Risk Index for Predicting Difficult Intubation

    The predictive performance of the Modified El-Ganzouri Risk Index (MEGRI) for difficult intubation will be evaluated using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC).

    Time frame: From preoperative airway assessment to completion of endotracheal intubation during surgery.

Secondary outcomes

  1. Area Under the Receiver Operating Characteristic Curve (AUC) of the Original El-Ganzouri Risk Index for Predicting Difficult Intubation

    The predictive performance of the original El-Ganzouri Risk Index (EGRI) for difficult intubation will be evaluated using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC).

    Time frame: From preoperative airway assessment to completion of endotracheal intubation during surgery.

Other outcomes

  1. Intubation Difficulty Score (IDS)

    The Intubation Difficulty Scale score will be recorded during tracheal intubation. An IDS score greater than 5 will indicate difficult intubation.

    Time frame: During endotracheal intubation

  2. Sensitivity and Specificity of the Modified and Original El-Ganzouri Risk Indices for Predicting Difficult Intubation

    Difficult laryngoscopy will be defined as a Cormack-Lehane grade III or IV laryngeal view.

    Time frame: From preoperative airway assessment to completion of endotracheal intubation during surgery

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Mar 2027, 5 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 26, 2026
First posted
Oct 5, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Mar 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07857395
Lead sponsor
Zagazig University
Responsible party
Islam Ramzy Ahmed Ali (Dr., Zagazig University) — Principal investigator
First posted
Oct 5, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

Eslam Ramzy Ahmed
Contact
eslameljarrah@gmail.com
+201551210896

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion